Latest Stock Buy or Sell? Make More Informed Decisions!

Today, Mike S. Newton, CIM FCSI commented about whether SU.TO, MRK, U.TO, PD.TO, HNU.TO, SC.TO, SLF.TO, BRK.B, PAC, ATD.B.TO, CCT.TO, PBE, CGX.TO, TRI.TO are stocks to buy or sell.

TOP PICK
This is a company that can re-ignite itself if the economy picks up. The merger with Reuters has worked out. Investors will recognize the quality of its cash flow.
TOP PICK
Have 75% market share. Cash flow is great. 7.5% yield.
TOP PICK
Bio & Genome ETF. Expect there will be massive changes in nanotechnology, stem cell research, etc. in the next 4 to 5 years. This is the only way to buy all the very small NASDAQ traded names and one of them is going to hit it rich.
PAST TOP PICK
(A Top Pick Aug 11/09. Up13.74%.) But stopped out but would still like to get it at the right price.
PAST TOP PICK
(A Top Pick Aug 11/09. Up 14.98%.) Still a buy.
PAST TOP PICK
(A Top Pick Aug 11/09. Up 13.38%.) Still a buy.
HOLD
Just split the shares so it is now included in the S&P 500. Looks very attractive. Probably the world's best money manager managing it. Probably a fairly expensive management fee. Has probably had its run in the short-term, so just watch.
DON'T BUY
The fact that they didn't cut the dividend is a very positive sign. Prefers this one over Manulife (MFC-T) because of all the issues over Manulife. Not interested in the insurance business right now. Better places to put your money.
HOLD
Stock hasn't moved because of pending Ontario legislation on dispensing fees. Would rather own something else than waiting for an announcement.
DON'T BUY
Natural Gas Bull+ ETF. He is very bullish on gas but this would not be the name he would use to access it. Consider Claymore Natural Gas Commodity (GAS-T), or better yet own a large cap gas company.
HOLD
Likes the drilling companies but we need a little more evidence of the global turnaround to really get going.
COMMENT
Gold. Gold is a currency play more so than an inflation play. If you're going to be in gold, have 5%-10% weighting in your portfolio as a hedge to make it worth your while.
DON'T BUY
Uranium is in equilibrium right now. There are global utilities and governments that are going to need to secure their uranium supplies so he expects to see a lot of M&A activity in uranium. This one is the actual physical holding of uranium.
BUY
Large-cap pharmaceuticals are probably the best valuation out there. Their recent merger is all done. An excellent buy at this level.
DON'T BUY
You have to let this one workout. Not only the Petrocan deal but was probably one of the darlings that was over owned. Expects a long period of consolidation with this name.